Predictive factors of radiation-induced skin toxicity in breast cancer patients

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Chen, Miao Fen ^a,b   Chen, Wen Cheng ^a,b   Lai, Chia Hsuan ^a   Hung, Chao Hsiung ^a   Liu, Kuo Chi ^a   Cheng, Yin Hsuan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 6; MOMETASONE FUROATE; STEROID; TRANSFORMING GROWTH FACTOR BETA1;

ADJUVANT THERAPY; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DESQUAMATION; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MOUSE; NONHUMAN; PREDICTION; PROTEIN EXPRESSION; RADIATION DERMATITIS; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SKIN CARE; SKIN TOXICITY; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; FEMALE; METHODOLOGY; MIDDLE AGED; RADIATION INJURY; RADIOTHERAPY; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY, CONFORMAL; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956881279     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-508     Document Type: Article

References (32)

1. Gebski V, Lagleva M, Keech A, Simes J, Langlands AO. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Natl Cancer Inst 2006, 98:26-38. 10.1093/jnci/djj002, 16391369.
2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241. 10.1056/NEJMoa022152, 12393820.
3. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
4. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005, 6:557-565. 10.1016/S1470-2045(05)70251-5, 16054566.
5. Matzinger O, Heimsoth I, Poortmans P, Collette L, Struikmans H, Van Den Bogaert W, Fourquet A, Bartelink H, Ataman F, Gulyban A, Pierart M, Van Tienhoven G. EORTC Radiation Oncology & Breast Cancer Groups. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 2010, 49:24-34. 10.3109/02841860903352959, 20100142.
6. Chen MF, Tseng CJ, Tseng CC, Kuo YC, Yu CY, Chen WC. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1438-1444.
7. Ares C, Khan S, Macartain AM, Heuberger J, Goitein G, Gruber G, Lutters G, Hug EB, Bodis S, Lomax AJ. Postoperative Proton Radiotherapy for Localized and Locoregional Breast Cancer: Potential for Clinically Relevant Improvements?. Int J Radiat Oncol Biol Phys 2010, 76:685-97.
8. Moon SH, Shin KH, Kim TH, Yoon M, Park S, Lee DH, Kim JW, Kim DW, Park SY, Cho KH. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol 2009, 90:66-73. 10.1016/j.radonc.2008.09.027, 18992950.
9. Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, Vu TT, Truong P, Ackerman I, Paszat L. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008, 26:2085-92. 10.1200/JCO.2007.15.2488, 18285602.
10. Morganti AG, Cilla S, Valentini V, Digesu' C, Macchia G, Deodato F, Ferrandina G, Cece MG, Cirocco M, Garganese G, Di Lullo L, Traficante D, Scarabeo F, Panunzi S, De Gaetano A, Sallustio G, Cellini N, Sofo L, Piermattei A, Scambia G. Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. Radiother Oncol 2009, 90:86-92. 10.1016/j.radonc.2008.10.017, 19010560.
11. Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder DM, Elias PM, Fritsch PO, Fritsch E. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol 2002, 146:983-91. 10.1046/j.1365-2133.2002.04751.x, 12072066.
12. Boström A, Lindman H, Swartling C, Berne B, Bergh J. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol 2001, 59:257-65. 10.1016/S0167-8140(01)00327-9, 11369066.
13. Pardo Masferrer J, Murcia Mejía M, Vidal Fernández M, Alvarado Astudillo A, Hernández Armenteros ML, Macías Hernández V, Soto Pérez R, Mirada Ferre A. Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis. Clin Transl Oncol 2010, 12:43-8. 10.1007/s12094-010-0465-0, 20080470.
14. Koh WJ, Stelzer KJ, Peterson LM, Staker BL, Ward WF, Russell KJ, Griffin TW. Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats. Int J Radiat Oncol Biol Phys 1995, 31:71-7.
15. Wu CT, Chen WC, Lin PY, Liao SK, Chen MF. Androgen deprivation modulates the inflammatory response induced by irradiation. BMC Cancer 2009, 9:92. 10.1186/1471-2407-9-92, 2667536, 19320990.
16. Fleckenstein K, Gauter-Fleckenstein B, Jackson IL, Rabbani Z, Anscher M, Vujaskovic Z. Using biological markers to predict risk of radiation injury. Semin Radiat Oncol 2007, 17:89-98. 10.1016/j.semradonc.2006.11.004, 17395039.
17. Halperin EC, Gaspar L, George S, Darr D, Pinnell S. A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys 1993, 26:413-416.
18. Potera ME, Lookingbill DP, Stryker JA. Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiology 1982, 143:775-777.
19. Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL, Urias RE, Kuske RR, Engel RE, Eggleston WD. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996, 36:345-349.
20. Xiao Z, Su Y, Yang S, Yin L, Wang W, Yi Y, Fenton BM, Zhang L, Okunieff P. Protective effect of esculentoside A on radiation-induced dermatitis and fibrosis. Int J Radiat Oncol Biol Phys 2006, 65:882-889.
21. Chen MF, Keng PC, Lin PY, Yang CT, Liao SK, Chen WC. Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo. BMC Cancer 2005, 5:158. 10.1186/1471-2407-5-158, 1325253, 16336675.
22. Ostrau C, Hülsenbeck J, Herzog M, Schad A, Torzewski M, Lackner KJ, Fritz G. Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. Radiother Oncol 2009, 92:492-499. 10.1016/j.radonc.2009.06.020, 19615773.
23. Rodemann HP, Blaese MA. Responses of normal cells to ionizing radiation. Semin Radiat Oncol 2007, 17:81-88. 10.1016/j.semradonc.2006.11.005, 17395038.
24. Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride WH. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol 2007, 17:121-130. 10.1016/j.semradonc.2006.11.008, 17395042.
25. Anscher MS, Vujaskovic Z. Mechanisms and potential targets for prevention and treatment of normal tissue injury after radiation therapy. Semin Oncol 2005, 32:S86-91. 10.1053/j.seminoncol.2005.03.015, 16015541.
26. Linard C, Marquette C, Mathieu J, Pennequin A, Clarencon D, Mathe D. Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kappaB inhibitor. Int J Radiat Oncol Biol Phys 2004, 58:427-434.
27. Martin M, Lefaix J, Delanian S. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?. Int J Radiat Oncol Biol Phys 2000, 47:277-290. 10.1016/S0360-3016(00)00435-1, 10802350.
28. Anscher MS, Kong FM, Andrews K, Clough R, Marks LB, Bentel G, Jirtle RL. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 1998, 41:1029-1035.
29. Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, Finkelstein JN, Rubin P, Okunieff P. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 2002, 12:26-33. 10.1053/srao.2002.31360, 11917281.
30. Meeran SM, Akhtar S, Katiyar SK. Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. J Invest Dermatol 2009, 129:1258-1270. 10.1038/jid.2008.354, 2669839, 19020550.
31. Kobayashi H, Yazlovitskaya EM, Lin PC. Interleukin-32 positively regulates radiation-induced vascular inflammation. Int J Radiat Oncol Biol Phys 2009, 74:1573-1579. 2713876, 19616744.
32. Gu M, Singh RP, Dhanalakshmi S, Agarwal C, Agarwal R. Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res 2007, 67:3483-3491. 10.1158/0008-5472.CAN-06-3955, 17409458.